During Tuesday’s Current trade, Shares of Chimera Investment Corporation (NYSE:CIM), lost -0.21% to $14.06.
Chimera Investment Corporation (CIM) and Annaly Capital Administration, Inc. jointly declared that, effective recently, Chimera is internalizing its administration function. The independent directors on Chimera’s Board agreed to the internalization with Annaly in order to accelerate growth and realize cost efficiencies. Chimera will continue to be led by its key professionals counting President and Chief Executive Officer Matthew Lambiase, Chief Financial Officer Rob Colligan and Chief Investment Officer Mohit Marria. In addition, Chimera’s head of structured products, Choudhary Yarlagadda, was designated Chief Operating Officer and Phillip J. Kardis II, a partner at the law firm K&L Gates LLP, was designated General Counsel. All other personnel that focus their efforts on Chimera’s business became employees of Chimera.
Chimera Investment Corporation operates as a real estate investment trust in the United States. The company, through its auxiliaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes. Its targeted asset classes comprise non-agency RMBS, such as investment-grade and non-investment grade classes; agency RMBS; interest-only RMBS; and first or second lien loans secured by multifamily properties, mixed residential or other commercial properties, retail properties, office properties, and industrial properties.
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), declined -0.36% to $11.20, during its current trading session.
Ironwood Pharmaceuticals, Inc. (IRWD) declared a contract with Allergan plc for the U.S. co-promotion of VIBERZI™ (eluxadoline), Allergan’s new treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D). This arrangement is separate from and complementary to the companies’ ongoing co-development and co-commercialization of LINZESS® (linaclotide) for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).
Under the terms of the agreement, Ironwood’s clinical sales specialists will detail VIBERZI to the about 25,000 health care practitioners to whom they presently detail LINZESS and Cologuard. LINZESS will remain the first-position product for the Ironwood sales team. Ironwood’s promotional efforts will be compensated based on the volume of calls delivered by Ironwood’s sales force, in addition to agreed upon performance metrics. Allergan will be responsible for all other costs regardingthe commercialization of VIBERZI. The co-promotion will start as soon as VIBERZI is commercially accessible.
Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Constella name in the European Union.
Becton, Dickinson and Co. (NYSE:BDX), during its Tuesday’s current trading session decreased -1.33% to $148.30.
BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, declared recently an updated sustainability strategy and aims for 2020 as part of the release of its 2014 Sustainability Report.
The company’s new aims reflect a broader and more integrated agenda than in past years, recognizing four planned areas where BD will focus its efforts and reporting going forward:
- Innovation – health care safety, reach and cost
- Access – health care in resource-limited populations
- Efficiency – environmentally sound products and resilient operations
- Empowerment – positive workforce and community impacts
This is BD’s seventh annual Sustainability Report, highlighting progress achieved within the company’s past fiscal year between Oct. 1, 2013 and Sept. 30, 2014. The company plans to continue its long history of shared value creation, which addresses unmet societal needs through business models and initiatives that also contribute to commercial success.
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company’s BD Medical segment produces medical devices, such as needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for use in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices.Finally, Angie’s List Inc (NASDAQ:ANGI), decreased -0.61%, to $4.86.
Summer is well under way, and that means the dulcet tones of hammers and saws will be filling the air in neighborhoods across America.
Requests for information on remodeling contractors in June, July and August account for about one-third of the total remodeling requests for the other nine months of the year. Angie’s List members conducted nearly 80,000 searches for remodeling contractors in June alone.
Angie’s List (ANGI) has gathered consumer reviews on home-related, local service companies for 20 years. In a November 2014 Angie’s List survey of more than 1,000 service providers, 62 percent said they were expecting bigger budget projects contrast to last season.
Angie’s List, Inc. operates a local services marketplace and consumer review site in the United States. The company provides marketplace to research, shop for, and purchase local services for home, health, and automotive service needs. It also allows its consumers to rate and review service providers in 253 markets. In addition, the company provides advertising services to service providers through its monthly publication and call center; and on its Website, in addition to through mobile applications. Further, its e-commerce marketplace offers consumers to purchase services directly through its marketplace from service providers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
